|Bid||104.15 x 1800|
|Ask||106.09 x 800|
|Day's Range||103.13 - 105.55|
|52 Week Range||61.61 - 114.20|
|Beta (5Y Monthly)||0.91|
|PE Ratio (TTM)||55.58|
|Earnings Date||Jan 20, 2021 - Jan 25, 2021|
|Forward Dividend & Yield||1.44 (1.37%)|
|Ex-Dividend Date||Oct 14, 2020|
|1y Target Est||119.24|
Commerzbank, Germany’s second-largest lender, exited positions in Comcast, Barrick Gold, and Berkshire Hathaway stock in the third quarter. It initiated an investment in Abbott Laboratories.
Moderna (NASDAQ: MRNA) is without a doubt one of the most talked about coronavirus stocks these days. The company was the first to launch its coronavirus vaccine candidate in human trials and is still a leader in the race to the finish line. Sure, Abbott is only up around 25% this year.
“It’s hard to argue that the country doesn’t have infrastructure problems,” says Scott Davis, CEO of Melius Research. Well, there’s a giant need for greater and more accurate coronavirus testing and tracing capabilities—and that will help the companies that supply them. (ABT)’ (ticker: ABT) six coronavirus tests drove a 39% gain in third-quarter diagnostic sales.